Skip to main content
L

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. — Investor Relations & Filings

Ticker · 2291 HKEX Manufacturing
Open in API
Filings indexed 148 across all filing types
Latest filing 2026-04-23 Notice of Dividend Amou…
Country HK Hong Kong
Listing HKEX 2291

About LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.

http://www.scientechmed.com

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. specializes in the research, development, manufacturing, and commercialization of advanced interventional medical devices. The core focus is on structural heart diseases, encompassing solutions for congenital heart defects, heart valve conditions, and the prevention of cardiogenic stroke. The company's product portfolio includes specialized interventional treatment series, such as coronary heart disease occluder products and heart valve medical devices. Leveraging innovation in interventional cardiology, the company aims to provide comprehensive healthcare solutions for complex structural heart conditions globally.

Recent filings

Filing Released Lang Actions
Final Dividend for the year ended 31 December 2025 (updated)
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement by a Hong Kong listed issuer detailing a final cash dividend for the year ended 31 December 2025, including the dividend amount per share, ex-dividend date, record date, payment date, withholding tax details, and other dividend logistics. This precisely matches the definition of a Notice of Dividend Amount (Code: DIV).
2026-04-23 English
PROXY FORM FOR THE 2025 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 22, 2026 OR ANY ADJOURNMENT THEREOF
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a proxy form for the 2025 Annual General Meeting, providing shareholders with materials to appoint proxies and cast votes in advance. This is a solicitation of shareholder votes and falls under materials sent to shareholders to request votes for a meeting, which matches the Proxy Solicitation & Information Statement category (PSI).
2026-04-23 English
NOTICE OF THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is the formal “Notice of the 2025 Annual General Meeting,” listing resolutions to be voted on, proxy appointment details, meeting date and venue, and instructions for shareholders to submit proxies. It is sent to shareholders to provide meeting information and solicit votes, matching “Proxy Solicitation & Information Statement (PSI).”
2026-04-23 English
CIRCULAR OF THE 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular containing the notice of the 2025 Annual General Meeting, detailed explanatory statements on proposed resolutions (work reports, annual report, auditor’s report, budget plan, remuneration, dividend plan, auditor reappointment, share issue mandates), and the form of proxy for voting. This is precisely a proxy solicitation/information statement sent to shareholders to request their votes at the AGM. Therefore, it matches the definition of a Proxy Solicitation & Information Statement (Code: PSI).
2026-04-23 English
2025 ANNUAL REPORT
Annual Report Classification · 1% confidence The document is explicitly titled '2025 Annual Report' and contains comprehensive sections typical of a full annual report, including corporate information, financial highlights, management discussion and analysis, auditor's report, and consolidated financial statements. It is not an announcement of a report, but the report itself. FY 2025
2026-04-23 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2026
Regulatory Filings Classification · 1% confidence The document is an HKEX FF301 form titled “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities” for the month ended 31 March 2026. It details authorized/registered share capital movements, issued shares, public float sufficiency, and confirmations per Main Board/GEM rules. This is a routine regulatory filing of share capital movements, not an earnings release, AGM materials, management update, or transaction notice. It does not match any specialized category except the generic regulatory filing category. Therefore, it should be classified as Regulatory Filings (RNS).
2026-04-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.